Integer Holdings Corporation (NYSE:ITGR) is reporting third quarter financial results on Thursday 29th October 2020, before market open.
According to analysts surveyed by Thomson Reuters, ITGR is expected to report 3Q20 income of $ 0.36 per share from revenue of $ 240.23 million.
For the full year, analysts anticipate top line of $ 1090.85 million, while looking forward to income of $ 2.70 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,290.00 million ~ $ 1,310.00 million, where as bottomline are predicted in a range of $ 5.10 ~ $ 5.30 per share
Click Here For More Historical Outlooks Of Integer Holdings Corporation
Previous Quarter Performance
Integer Holdings Corporation unwinded income for the second quarter of $ 0.32 per share, from the revenue of $ 240.12 million. The quarterly earnings fell 73.98 percent while revenues decreased 23.57 percent compared with the same quarter last year.
According to street consensus, ITGR was expected to report 2Q20 income of $ 0.40 per share from revenue of $ 241.90 million. The bottom line results missed street analysts by $ 0.08 or 20 percent, at the same time, top line results fell short of analysts by $ 1.78 million or 0.74 percent.
Stock Performance
Shares of Integer Holdings Corporation traded low $ -2.79 or -4.38 percent on Wednesday, reaching $ 60.94 with volume of 252.50 thousand shares. Integer Holdings Corporation has traded high as $ 62.63 and has cracked $ 60.61 on the downward trend
According to the previous trading day, closing price of $ 60.94, representing a 38.51 % increase from the 52 week low of $ 46.01 and a 36.24 % decrease over the 52 week high of $ 99.95.
The company has a market capital of $ 2.00 billion and is part of the Healthcare sector and Medical Devices industry.
Conference Call
Integer Holdings Corporation will be hosting a conference call at 9:00 AM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.integer.net
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
